Agreement Between Patient and Physician Assessment of Eyebrow and Eyelash Hair Loss in Two Phase 3 Trials Evaluating Baricitinib in Patients with Severe Alopecia Areata. (2023). SKIN The Journal of Cutaneous Medicine, 7(6), s295. https://doi.org/10.25251/skin.7.supp.295